Key Takeaways
- SMCI stock jumped more than 17% following fiscal Q3 2026 results, with non-GAAP EPS of $0.84 crushing the $0.63 estimate by approximately 33%
- Revenue significantly underperformed at $10.24B compared to the $12.39B consensus — a 17% miss
- Gross margins improved dramatically to 10.1% from the previous quarter’s 6.4%, though Q4 projections suggest a decline to 8.2%–8.4%
- Operating cash flow plummeted to negative $6.6 billion, pushing net debt to $7.5 billion
- Wall Street remains divided with a “Hold” consensus and average price target of $38.43, as legal and compliance concerns persist
Super Micro Computer (SMCI) stock kicked off Friday’s trading session at $33.46, carrying a market capitalization of $20.12 billion. Shares rocketed over 17% higher after the company released its fiscal Q3 2026 financial results — though a deeper examination reveals a mixed picture.
Super Micro Computer, Inc., SMCI
Quarterly revenue reached $10.24 billion, representing a robust 122.7% increase compared to the same period last year, yet falling considerably short of Wall Street’s $12.39 billion projection. Conversely, earnings per share hit $0.84, handily surpassing the analyst consensus of $0.63 by roughly 33%.
The quarter’s most compelling narrative centers on profitability metrics. Gross margin staged a notable recovery to 10.1%, climbing from a troubling 6.4% in the preceding quarter. This turnaround stemmed primarily from product mix optimization — AI GPU systems now represent over 80% of total revenue and deliver superior margin profiles.
However, this margin expansion appears temporary. The company’s Q4 outlook projects EPS between $0.65 and $0.79, with gross margins expected to contract back to the 8.2%–8.4% corridor as cost headwinds reemerge.
Severe Cash Flow Deterioration Demands Attention
The financial statement that raises the most concern is the cash flow report. Operating cash flow cratered to a staggering negative $6.6 billion. Inventory balances have swelled to $11.1 billion, while net debt has climbed to $7.5 billion.
Working capital requirements are escalating rapidly as the business expands to fulfill AI infrastructure demand. This magnitude of cash consumption creates anxiety among investors, despite the compelling revenue growth narrative.
Management projects long-term revenue expansion from $40 billion approaching $60 billion by fiscal 2028, with annualized production capacity targets exceeding $100 billion. The forward price-to-earnings ratio stands around 12.9x — appearing attractive relative to technology sector norms, though this valuation discount acknowledges substantial risk factors.
Customer concentration metrics have shown improvement, declining from 63% to 27%. Enterprise channel revenues surged 45% on a sequential basis — representing one of the quarter’s most encouraging developments.
Ongoing Legal and Compliance Challenges
SMCI’s legal environment remains complex and troubling. A Department of Justice investigation continues. Several securities class action lawsuits feature lead-plaintiff motion deadlines converging around May 25–26. A recent complaint filed by Hagens Berman claims the company distributed AI servers containing export-controlled Nvidia chips to Chinese customers via a Southeast Asian shell company.
Taiwanese law enforcement officials are also reportedly pursuing detention orders in a related smuggling investigation. These legal matters represent significant concerns — not peripheral issues — and continue suppressing the stock’s valuation despite favorable AI industry trends.
Regarding executive changes, SMCI designated Vik Malyala as Chief Business Officer on May 11 and appointed Matthew Thauberger as Chief Revenue Officer on May 14, succeeding longtime sales executive Don Clegg who retired.
Institutional investors control 84% of outstanding shares. North Dakota State Investment Board established a fresh position during Q4, acquiring 17,620 shares worth approximately $516,000.
Wall Street analysts updated their price targets post-earnings: Northland elevated its objective from $22 to $34, JPMorgan adjusted from $28 to $32 while maintaining a “neutral” stance, and Wedbush reduced its target from $42 to $34, also rating neutral. The average analyst price target stands at $38.43, with the rating breakdown showing four Buy recommendations, eleven Hold ratings, and two Sell ratings.
